{"id":863403,"date":"2025-06-24T16:30:45","date_gmt":"2025-06-24T20:30:45","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\/"},"modified":"2025-06-24T16:30:45","modified_gmt":"2025-06-24T20:30:45","slug":"rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\/","title":{"rendered":"Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before August 11, 2025 to Discuss Your Rights \u2013 RCKT"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, June  24, 2025  (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in <strong>Rocket Pharmaceuticals, Inc.<\/strong> (&#8220;Rocket&#8221; or the &#8220;Company&#8221;) (NASDAQ: RCKT) of a class action securities lawsuit.<\/p>\n<p>\n        <strong>CLASS DEFINITION: <\/strong>The lawsuit seeks to recover losses on behalf of Rocket investors who were adversely affected by alleged securities fraud between February 27, 2025 and May 26, 2025. Follow the link below to get more information and be contacted by a member of our team:<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OqMsI5HOFtqvQtvkRXTOT5-5iSXdCmNg8d5j8HhyEkNNA_maF_wqQeE9WUXtcK2ou5qc6Cq3MVkxlMnh_b42BEPGgc3RIKPw_lZ5vJUVNfr3cN_Jw7uHmUPSha-iYMbLF42aOt25Q_aCw5QwasBc2VTqDoPcFpyPEg7sWm9X3DreOHzq-Zsv7AWpPvHa2KOp_NCd8MMheRpk4Mx_xj2IMQG-G-VchBr4MwyJnMz1qs6dmVQJkdIrxDQz7q3jdSnNwNZ8vbTXjh1vKeNKNXAE_8cVyKsga7boUM1JUPk8SMI=\" rel=\"nofollow\" target=\"_blank\">https:\/\/zlk.com\/pslra-1\/rocket-pharmaceuticals-inc-lawsuit-submission-form?prid=153983&amp;wire=3<\/a>\n      <\/p>\n<p>\n        <strong>RCKT<\/strong> investors may also contact Joseph E. Levi, Esq. via email at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=snDFatMe0EEK7CL3FjxEHt-fKgrfwBrEMPeeLj9mRM5exCyGyIsfNb9jwLsjBDnyQ2-ynZckSHQN4rAJpP3rsP4sNu9O7pmGfLFPC--d6K8=\" rel=\"nofollow\" target=\"_blank\">jlevi@levikorsinsky.com<\/a>\u00a0or by telephone at (212) 363-7500.<\/p>\n<p>\n        <strong>CASE DETAILS: <\/strong>According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and\/or concealing material adverse facts concerning the true state of RP-A501\u2019s safety and clinical trial protocol; notably, that Rocket knew Serious Adverse Events (SAEs), including death of participants enrolled in the study, were a risk. In particular, Rocket amended the trial\u2019s protocol to introduce a novel immunomodulatory agent to the pretreatment regimen without providing this critical update to shareholders. Such statements absent these material facts caused Plaintiff and other shareholders to purchase Rocket\u2019s securities at artificially inflated prices. On May 27, 2025, Rocket announced that the FDA placed a clinical hold on the RP-A501 Phase 2 pivotal study after at least one patient suffered a Serious Adverse Event (SAE), ultimately, death, while enrolled in the study following a substantive amendment to the protocol that the Company failed to disclose to investors at the time management made the revision. In fact, Rocket stated that, while the patient was dosed in May, the decision to amend the protocol was made \u201cseveral months\u201d earlier. Despite this, Rocket made no attempt to alert investors or the public to the change until after the SAE occurred. Following this news, the price of Rocket\u2019s common stock declined dramatically. From a closing market price of $6.27 per share on May 23, 2025, Rocket\u2019s stock price fell to $2.33 per share on May 27, 2025, a decline of about 37% in the span of just a single trading day.<\/p>\n<p>\n        <strong>WHAT&#8217;S NEXT? <\/strong>If you suffered a loss in Rocket during the relevant time frame, you have until <strong>August 11, 2025<\/strong>\u00a0to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn&#8217;t require that you serve as a lead plaintiff.<\/p>\n<p>\n        <strong>NO COST TO YOU: <\/strong>If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. <strong>There is no cost or obligation to participate.<\/strong><\/p>\n<p>\n        <strong>WHY LEVI &amp; KORSINSKY: <\/strong>Over the past 20 years, the team at Levi &amp; Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi &amp; Korsinsky has ranked in ISS Securities Class Action Services\u2019 Top 50 Report as one of the top securities litigation firms in the United States.<\/p>\n<p>\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>Levi &amp; Korsinsky, LLP <br \/>Joseph E. Levi, Esq.<br \/>Ed Korsinsky, Esq.<br \/>33 Whitehall Street, 17th Floor<br \/>New York, NY 10004<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=snDFatMe0EEK7CL3FjxEHt-fKgrfwBrEMPeeLj9mRM7FXy1lXToComGe3f2ixurwSYjecoYaiIcfyRuNLwHOCkf24BW1ejLW7jkgY86DIFc=\" rel=\"nofollow\" target=\"_blank\">jlevi@levikorsinsky.com<\/a><br \/>Tel: (212) 363-7500<br \/>Fax: (212) 363-7171<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MnwsojHYadkZOmOjXg5saIEH-VQhezTp034C1-e3m3EJhIMbUThAgIqPAT4VeKLIjT4kjLkeA7UBH5vJy5BhTA==\" rel=\"nofollow\" target=\"_blank\">www.zlk.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4MzEzMCM3MDE0Mzk4IzIwMjA0MjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MGJhMGUxZWItMzYxMC00M2E3LWE5ODYtY2UzYmU4ZjA1ZGJhLTEwMzIyOTMtMjAyNS0wNi0yNC1lbg==\/tiny\/Levi-Korsinsky-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. (&#8220;Rocket&#8221; or the &#8220;Company&#8221;) (NASDAQ: RCKT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who were adversely affected by alleged securities fraud between February 27, 2025 and May 26, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/rocket-pharmaceuticals-inc-lawsuit-submission-form?prid=153983&amp;wire=3 RCKT investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and\/or concealing &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before August 11, 2025 to Discuss Your Rights \u2013 RCKT&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-863403","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before August 11, 2025 to Discuss Your Rights \u2013 RCKT - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before August 11, 2025 to Discuss Your Rights \u2013 RCKT - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. (&#8220;Rocket&#8221; or the &#8220;Company&#8221;) (NASDAQ: RCKT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who were adversely affected by alleged securities fraud between February 27, 2025 and May 26, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/rocket-pharmaceuticals-inc-lawsuit-submission-form?prid=153983&amp;wire=3 RCKT investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and\/or concealing &hellip; Continue reading &quot;Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before August 11, 2025 to Discuss Your Rights \u2013 RCKT&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-24T20:30:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4MzEzMCM3MDE0Mzk4IzIwMjA0MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before August 11, 2025 to Discuss Your Rights \u2013 RCKT\",\"datePublished\":\"2025-06-24T20:30:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\\\/\"},\"wordCount\":559,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4MzEzMCM3MDE0Mzk4IzIwMjA0MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\\\/\",\"name\":\"Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before August 11, 2025 to Discuss Your Rights \u2013 RCKT - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4MzEzMCM3MDE0Mzk4IzIwMjA0MjY=\",\"datePublished\":\"2025-06-24T20:30:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4MzEzMCM3MDE0Mzk4IzIwMjA0MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4MzEzMCM3MDE0Mzk4IzIwMjA0MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before August 11, 2025 to Discuss Your Rights \u2013 RCKT\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before August 11, 2025 to Discuss Your Rights \u2013 RCKT - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\/","og_locale":"en_US","og_type":"article","og_title":"Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before August 11, 2025 to Discuss Your Rights \u2013 RCKT - Market Newsdesk","og_description":"NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. (&#8220;Rocket&#8221; or the &#8220;Company&#8221;) (NASDAQ: RCKT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who were adversely affected by alleged securities fraud between February 27, 2025 and May 26, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/rocket-pharmaceuticals-inc-lawsuit-submission-form?prid=153983&amp;wire=3 RCKT investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and\/or concealing &hellip; Continue reading \"Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before August 11, 2025 to Discuss Your Rights \u2013 RCKT\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\/","og_site_name":"Market Newsdesk","article_published_time":"2025-06-24T20:30:45+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4MzEzMCM3MDE0Mzk4IzIwMjA0MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before August 11, 2025 to Discuss Your Rights \u2013 RCKT","datePublished":"2025-06-24T20:30:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\/"},"wordCount":559,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4MzEzMCM3MDE0Mzk4IzIwMjA0MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\/","name":"Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before August 11, 2025 to Discuss Your Rights \u2013 RCKT - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4MzEzMCM3MDE0Mzk4IzIwMjA0MjY=","datePublished":"2025-06-24T20:30:45+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4MzEzMCM3MDE0Mzk4IzIwMjA0MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4MzEzMCM3MDE0Mzk4IzIwMjA0MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-august-11-2025-to-discuss-your-rights-rckt-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact Levi &amp; Korsinsky Before August 11, 2025 to Discuss Your Rights \u2013 RCKT"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/863403","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=863403"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/863403\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=863403"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=863403"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=863403"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}